OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural killer cell cytotoxicity and its regulation by inhibitory receptors
Santosh Kumar
Immunology (2018) Vol. 154, Iss. 3, pp. 383-393
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Tobias Bald, Matthew F. Krummel, Mark J. Smyth, et al.
Nature Immunology (2020) Vol. 21, Iss. 8, pp. 835-847
Open Access | Times Cited: 370

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
Kyle B. Lupo, Sandro Matosevic
Cancers (2019) Vol. 11, Iss. 6, pp. 769-769
Open Access | Times Cited: 167

Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Yuqing Cao, Xiaoyu Wang, Tianqiang Jin, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 120

Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
Jianguang Zhang, Huifang Zheng, Yong Diao
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 2, pp. 317-317
Open Access | Times Cited: 115

Organization of the Skin Immune System and Compartmentalized Immune Responses in Infectious Diseases
Juarez Antônio Simões Quaresma
Clinical Microbiology Reviews (2019) Vol. 32, Iss. 4
Open Access | Times Cited: 113

CAR-NK Cells: From Natural Basis to Design for Kill
Muhammad Babar Khawar, Haibo Sun
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 95

β2 Integrins—Multi-Functional Leukocyte Receptors in Health and Disease
Monika Bednarczyk, Henner Stege, Stephan Grabbe, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1402-1402
Open Access | Times Cited: 86

Research Progress on NK Cell Receptors and Their Signaling Pathways
Yingying Chen, Dan Lu, Alexey V. Churov, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 81

Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab
Guoxu Zheng, Zhangyan Guo, Weimiao Li, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 75

Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms
Ganping Wang, Ming Zhang, Maosheng Cheng, et al.
Cancer Letters (2021) Vol. 507, pp. 55-69
Open Access | Times Cited: 74

Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival
Carlo Sorrentino, Luigi D’Antonio, Cristiano Fieni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 57

Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer
Mona M. Elanany, Dina Mostafa, Nadia Μ. Hamdy
Life Sciences (2023) Vol. 330, pp. 121997-121997
Closed Access | Times Cited: 32

Chronic stress in solid tumor development: from mechanisms to interventions
Jiajing Yan, Yibing Chen, Minhua Luo, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 29

Unraveling the dynamic mechanisms of natural killer cells in viral infections: insights and implications
Arash Letafati, Omid Salahi Ardekani, Mina Naderisemiromi, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13

Natural killer cell-mediated immune surveillance in cancer: Role of tumor microenvironment
Mohamed J. Saadh, Irodakhon Rasulova, Mohammed N. A. Khalil, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155120-155120
Closed Access | Times Cited: 9

NK Cells as Potential Targets for Immunotherapy in Endometriosis
Aneta Ścieżyńska, Michał Komorowski, Marta Soszyńska, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1468-1468
Open Access | Times Cited: 70

NK cell-based therapeutics for lung cancer
A. Graham Pockley, Peter Vaupel, Gabriele Multhoff
Expert Opinion on Biological Therapy (2019) Vol. 20, Iss. 1, pp. 23-33
Closed Access | Times Cited: 70

Two to Tango: Co-evolution of Hominid Natural Killer Cell Receptors and MHC
Emily E. Wroblewski, Peter Parham, Lisbeth A. Guethlein
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 59

CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
Faroogh Marofi, Marwan Mahmood Saleh, Heshu Sulaiman Rahman, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 52

Gene regulation of intracellular adhesion molecule-1 (ICAM-1): A molecule with multiple functions
Mona Singh, Mony Thakur, Manish Mishra, et al.
Immunology Letters (2021) Vol. 240, pp. 123-136
Closed Access | Times Cited: 52

Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia
Agata Pastorczak, Krzysztof Domka, Klaudyna Fidyt, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1536-1536
Open Access | Times Cited: 48

Assembly of Tetraspanin-enriched macrodomains contains membrane damage to facilitate repair
Yuwei Huang, Xing Zhang, Hongwei Wang, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 6, pp. 825-832
Closed Access | Times Cited: 36

Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health
Nicholas R. Pollock, Genelle F. Harrison, Paul J. Norman
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 7, pp. 1763-1775
Open Access | Times Cited: 29

Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
Kerry A. Whalen, Kavya Rakhra, Naveen K. Mehta, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 18

Page 1 - Next Page

Scroll to top